Compare IPCA Labs with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TTK HEALTHCARE - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS TTK HEALTHCARE IPCA LABS/
TTK HEALTHCARE
 
P/E (TTM) x 26.4 19.3 136.8% View Chart
P/BV x 4.4 1.5 285.3% View Chart
Dividend Yield % 0.3 1.0 27.5%  

Financials

 IPCA LABS   TTK HEALTHCARE
EQUITY SHARE DATA
    IPCA LABS
Mar-19
TTK HEALTHCARE
Mar-19
IPCA LABS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,0421,215 85.8%   
Low Rs590610 96.7%   
Sales per share (Unadj.) Rs298.6444.4 67.2%  
Earnings per share (Unadj.) Rs35.017.2 202.9%  
Cash flow per share (Unadj.) Rs49.427.6 178.9%  
Dividends per share (Unadj.) Rs3.005.00 60.0%  
Dividend yield (eoy) %0.40.5 67.1%  
Book value per share (Unadj.) Rs247.1177.9 138.9%  
Shares outstanding (eoy) m126.3514.13 894.2%   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.72.1 133.1%   
Avg P/E ratio x23.352.9 44.1%  
P/CF ratio (eoy) x16.533.0 50.0%  
Price / Book Value ratio x3.35.1 64.4%  
Dividend payout %8.629.0 29.6%   
Avg Mkt Cap Rs m103,10812,894 799.6%   
No. of employees `00013.42.3 581.4%   
Total wages/salary Rs m7,8741,307 602.4%   
Avg. sales/employee Rs Th2,807.02,715.7 103.4%   
Avg. wages/employee Rs Th585.8565.3 103.6%   
Avg. net profit/employee Rs Th329.0105.4 312.1%   
INCOME DATA
Net Sales Rs m37,7326,279 600.9%  
Other income Rs m57778 744.3%   
Total revenues Rs m38,3096,356 602.7%   
Gross profit Rs m6,901496 1,392.4%  
Depreciation Rs m1,824147 1,243.5%   
Interest Rs m18934 558.3%   
Profit before tax Rs m5,465393 1,391.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042149 700.1%   
Profit after tax Rs m4,422244 1,814.6%  
Gross profit margin %18.37.9 231.7%  
Effective tax rate %19.137.9 50.3%   
Net profit margin %11.73.9 302.0%  
BALANCE SHEET DATA
Current assets Rs m23,7782,717 875.1%   
Current liabilities Rs m10,9751,571 698.7%   
Net working cap to sales %33.918.3 185.8%  
Current ratio x2.21.7 125.2%  
Inventory Days Days10432 322.7%  
Debtors Days Days6647 141.3%  
Net fixed assets Rs m20,368991 2,055.3%   
Share capital Rs m253141 178.8%   
"Free" reserves Rs m30,9712,373 1,305.2%   
Net worth Rs m31,2242,514 1,241.9%   
Long term debt Rs m1,4093 41,426.5%   
Total assets Rs m45,5074,158 1,094.4%  
Interest coverage x30.012.6 237.5%   
Debt to equity ratio x00 3,335.9%  
Sales to assets ratio x0.81.5 54.9%   
Return on assets %10.16.7 151.8%  
Return on equity %14.29.7 146.1%  
Return on capital %17.316.9 102.3%  
Exports to sales %45.93.6 1,279.0%   
Imports to sales %16.60.5 3,369.2%   
Exports (fob) Rs m17,308225 7,685.8%   
Imports (cif) Rs m6,26631 20,246.8%   
Fx inflow Rs m17,308225 7,685.8%   
Fx outflow Rs m6,26671 8,812.3%   
Net fx Rs m11,042154 7,165.9%   
CASH FLOW
From Operations Rs m4,923173 2,843.9%  
From Investments Rs m-1,56397 -1,619.8%  
From Financial Activity Rs m-1,832-307 596.2%  
Net Cashflow Rs m1,528-38 -4,052.3%  

Share Holding

Indian Promoters % 45.9 65.4 70.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 3.7 308.1%  
FIIs % 25.3 5.2 486.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 25.8 67.4%  
Shareholders   36,892 12,723 290.0%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  AJANTA PHARMA  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

IPCA LABS at All Time High; BSE HEALTHCARE Index Up 0.3% (Market Updates)

Nov 11, 2019 | Updated on Nov 11, 2019

IPCA LABS share price has hit an all time high at Rs 1,118 (up 3.7%). The BSE HEALTHCARE Index is up by 0.3%. Among the top gainers in the BSE HEALTHCARE Index today are IPCA LABS (up 3.7%) and SANOFI INDIA (up 1.4%). The top losers include STRIDES PHARMA SCIENCE and ALKEM LABORATORIES (down 0.2%).

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Generate Alpha over the Next Decade(Profit Hunter)

Oct 29, 2019

Here's your chance benefit from a safe approach to making money in stock markets .

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Nov 11, 2019 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - PFIZER COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS